Operating Lease, Right-of-Use Asset of PTC THERAPEUTICS, INC. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PTC THERAPEUTICS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • PTC THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $80,682,000, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PTC THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $80,682,000 +$21,217,000 +36% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $56,162,000 -$973,000 -1.7% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $57,317,000 -$33,869,000 -37% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $56,685,000 -$35,211,000 -38% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $59,465,000 -$34,607,000 -37% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $57,135,000 -$39,551,000 -41% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $91,186,000 -$8,345,000 -8.4% 31 Mar 2024 10-Q 25 Apr 2024 2024 Q1
Q4 2023 $91,896,000 -$10,534,000 -10% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $94,072,000 -$10,829,000 -10% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 $96,686,000 -$44,949,000 -32% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $99,531,000 +$23,438,000 +31% 31 Mar 2023 10-Q 27 Apr 2023 2023 Q1
Q4 2022 $102,430,000 +$25,009,000 +32% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $104,901,000 +$26,202,000 +33% 30 Sep 2022 10-Q 27 Oct 2022 2022 Q3
Q2 2022 $141,635,000 +$60,941,000 +76% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $76,093,000 -$6,289,000 -7.6% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $77,421,000 -$6,989,000 -8.3% 31 Dec 2021 10-K 21 Feb 2023 2022 FY
Q3 2021 $78,699,000 -$7,111,000 -8.3% 30 Sep 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 $80,694,000 +$51,219,000 +174% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $82,382,000 +$64,711,000 +366% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $84,410,000 +$70,717,000 +516% 31 Dec 2020 10-K 22 Feb 2022 2021 FY
Q3 2020 $85,810,000 +$72,102,000 +526% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $29,475,000 +$19,088,000 +184% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $17,671,000 +$6,971,000 +65% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $13,693,000 +$2,393,000 +21% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $13,708,000 30 Sep 2019 10-Q 30 Oct 2019 2019 Q3
Q2 2019 $10,387,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $10,700,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $11,300,000 01 Jan 2019 10-K 02 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.